1 result
  • tymlos

    (abaloparatide)
    Radius Health, Inc.
    TYMLOS is indicated for treating postmenopausal women and men with osteoporosis at high fracture risk, including those with previous osteoporotic fractures or multiple risk factors. It is suitable for patients intolerant to or who have failed other osteoporosis therapies, aiming to reduce fracture risk and increase bone density.